Published in Pjama Healthcare
Rethinking alarm therapy in children with enuresis and daytime symptoms
In clinical practice, children with nocturnal enuresis often present with additional lower urinary tract symptoms.
Daytime incontinence, urgency or frequency are common findings and frequently raise an important question:
Should alarm therapy be postponed until daytime symptoms are fully resolved?
For a long time, the implicit answer in many settings has been “yes.”
Current evidence suggests that this assumption deserves to be reconsidered.
Where the assumption comes from
The idea that daytime incontinence should be treated before initiating alarm therapy has been shaped by concerns about:
- bladder dysfunction interfering with treatment response
- reduced adherence in more complex cases
- fear of poor outcomes or unnecessary burden on families
As a result, some children experience delays in enuresis treatment, even when nocturnal symptoms are the main complaint.
What the evidence actually shows
Several studies, including real-world clinical data, indicate that daytime incontinence is not a reliable predictor of poor response to alarm therapy.
Key findings include:
- Children with daytime symptoms can respond to alarm treatment at similar rates as those without.
- Baseline daytime incontinence does not consistently predict non-response.
- Early treatment response remains a stronger prognostic factor than daytime symptoms alone.
In other words, the presence of daytime incontinence does not automatically justify withholding or delaying alarm therapy.
The importance of early response over baseline characteristics
Research increasingly points to a consistent pattern:
- Baseline data alone offers limited predictive value.
- What happens during the first weeks of treatment matters more.
Children who show early improvement in nocturnal enuresis are likely to benefit from continued alarm therapy — regardless of daytime symptoms.
Conversely, lack of early response should prompt reassessment, whether or not daytime incontinence is present.
This shifts the clinical focus from who qualifies to how the child responds.
Clinical implications: avoiding unnecessary delays
When alarm therapy is postponed solely due to daytime incontinence, several risks emerge:
- prolonged distress for the child and family
- loss of motivation before treatment even begins
- missed opportunity to assess nocturnal treatment response
- inefficient use of healthcare resources
Initiating alarm therapy while simultaneously addressing daytime symptoms can, in many cases, be both reasonable and effective.
Clinical judgement remains essential, particularly to rule out underlying pathology.
But complexity alone should not be equated with contraindication.
Supporting families through clear rationale
Families often struggle to understand why treatment is delayed when nighttime wetting is their primary concern.
When clinicians explain that:
- daytime symptoms do not necessarily prevent alarm success
- treatment will be monitored closely and reassessed early
- decisions are based on observed response rather than assumptions
…families tend to feel more involved, informed and reassured.
Clear reasoning strengthens trust and shared decision-making.
A more flexible, patient-centred approach
Modern enuresis care benefits from moving away from rigid treatment sequences and towards responsive, individualised pathways.
This means:
- initiating alarm therapy when nocturnal enuresis is the main complaint
- monitoring early response systematically
- addressing daytime symptoms in parallel when needed
- reassessing treatment based on progress rather than predefined exclusions
Such flexibility aligns clinical evidence with real-world patient needs.
Conclusion: complexity does not equal contraindication
Daytime incontinence is common in children with enuresis.
It reflects the multifactorial nature of lower urinary tract function — not an automatic barrier to alarm therapy.
By focusing on early treatment response rather than baseline assumptions, clinicians can:
- avoid unnecessary delays
- support families more effectively
- provide care that is both evidence-based and pragmatic
Alarm therapy should be guided by response, not by rigid exclusion criteria.
References
Nevéus T et al. Evaluation and treatment of monosymptomatic enuresis: ICCS standardization document. J Urol. 2010.
Larsson J, Borgström M, Karanikas B, Nevéus T. Predictors of response and adherence to enuresis alarm therapy. J Pediatr Urol. 2023.
Glazener CM, Evans JH. Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2005.
Franco I et al. Pediatric Incontinence: Evaluation and Clinical Management. Wiley Blackwell, 2015.
